Recent Faculty Publications
Our neurological research frequently appears in leading academic journals and reflects a broad scope of interests.
- Barzaghi L, Paoletti M, Monforte M, Bortolani S, Bonizzoni C, Thorsten F, Bergsland N, Santini F, Deligianni X, Tasca G, Ballante E, Figini S, Ricci E, Pichiecchio A. (2024) Muscle diffusion tensor imaging in facioscapulohumeral muscular dystrophy. Muscle & nerve (Aug), 70(2): 248-256.
- Zivadinov R, Schweser F, Jakimovski D, Bergsland N, Dwyer MG. (2024) Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging. Neuroimaging clinics of North America (Aug), 34(3): 453-468.
- Zivadinov R, Schweser F, Jakimovski D, Bergsland N, Dwyer MG. (2024) Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging. Neuroimaging clinics of North America (Aug), 34(3): 453-468.
- Katsanos AH, Poppe A, Swartz RH, Mandzia J, Catanese L, Shankar J, Yip S, Verreault S, Medvedev G, Maran I, Legault C, Ferguson D, Archer B, Bharatha A, Volders D, Kelly M, Carpani F, Pikula A, Tkach A, Moreau F, Beaudry M, Appireddy R, Deshmukh A, Almekhlafi M, Fahed R, Kamal N, Menon B, Shoamanesh A, Williams H, Yu AYX, Heran MKS, Hill MD, Sharma M, Earl K, Demchuk AM, Stotts G. (2024) Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry. Stroke (Aug), 55(8): 2103-2112. doi:10.1161/STROKEAHA.124.046690
- Liu YB, Arystarkhova E, Sacino AN, Szabari MV, Lutz CM, Terrey M, Morsci N, Jakobs TC, Lykke-Hartmann K, Brashear A, Napoli E, Sweadner KJ. (2024) Phenotype distinctions in mice deficient in the neuron-specific a3 subunit of Na,K-ATPase: Atp1a3+/- and Atp1a3+/D801Y. eNeuro (Aug)(2024 Aug 28;11(8):ENEURO.0101-24.2024) doi:10.1523/ENEURO.0101-24.2024
- Eckert S, Jakimovski D, Zivadinov R, Hicar M, Weinstock-Guttman B. (2024) How to and should we target EBV in MS?. Expert review of clinical immunology (Jul), 20(7): 703-714.
- Jakimovski D, Weinstock-Guttman B, Burnham A, Weinstock Z, Wicks TR, Ramanathan M, Sciortino T, Ostrem M, Suchan C, Dwyer MG, Reilly J, Bergsland N, Schweser F, Kennedy C, Young-Hong D, Eckert SP, Hojnacki D, Benedict RH, Zivadinov R. (2024) Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105630.
- Jakimovski D, Weinstock-Guttman B, Burnham A, Weinstock Z, Wicks TR, Ramanathan M, Sciortino T, Ostrem M, Suchan C, Dwyer MG, Reilly J, Bergsland N, Schweser F, Kennedy C, Young-Hong D, Eckert SP, Hojnacki D, Benedict RH, Zivadinov R. (2024) Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105630.
- Jakimovski D, Weinstock-Guttman B, Burnham A, Weinstock Z, Wicks TR, Ramanathan M, Sciortino T, Ostrem M, Suchan C, Dwyer MG, Reilly J, Bergsland N, Schweser F, Kennedy C, Young-Hong D, Eckert SP, Hojnacki D, Benedict RH, Zivadinov R. (2024) Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105630.
- Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Weinstock-Guttman B, Zivadinov R. (2024) Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105668.
- Jakimovski D, Qureshi F, Ramanathan M, Keshavan A, Leyden K, Jalaleddini K, Ghoreyshi A, Dwyer MG, Bergsland N, Marr K, Weinstock-Guttman B, Zivadinov R. (2024) Lower arterial cerebral blood flow is associated with worse neuroinflammation and immunomodulation composite proteomic scores. Multiple sclerosis and related disorders (Jul), 87: 105687.
- Fuchs TA, Zivadinov R, Pryshchepova T, Weinstock-Guttman B, Dwyer MG, Benedict RHB, Bergsland N, Jakimovski D, Uher T, Jelgerhuis JR, Barkhof F, Uitdehaag BMJ, Killestein J, Strijbis EMM, Schoonheim MM. (2024) Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis. Multiple sclerosis and related disorders (Jul), 89: 105755.
- Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E, Dwyer MG, Bergsland N. (2024) Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis. Biomolecules (Jul), 14(7). doi:10.3390/biom14070824
- Wicks TR, Jakimovski D, Reeves J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R. (2024) Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: A 15-year follow-up study. Journal of the neurological sciences (Jul), 464: 123156.
- Schwamm LH, Kamel H, Granger CB, Piccini JP, Katz JM, Sethi PP, Sidorov EV, Kasner SE, Silverman SB, Merriam TT, Franco N, Ziegler PD, Bernstein RA; STROKE AF Investigators. (2024) Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial. JAMA Neurol (Jun), 80(1): 99-103. doi:10.1001/jamaneurol.2022.4038
- GBD Spinal Cord Injuries Collaborators. (2024) Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol (Jun), 11(22): 1026-1047. doi:10.1016/S1474-4422(23)00287-9
- Jakimovski D, Qureshi F, Ramanathan M, Jalaleddini K, Ghoreyshi A, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2024) Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation. Journal of the neurological sciences (Jun), 461: 123055.
- Kaminski HJ, Kusner LL, Cutter GR, Le Panse R, Wright CD, Perry Y, Wolfe GI. (2024) Does Surgical Removal of the Thymus Have Deleterious Consequences?. Neurology (Jun), 102(12): e209482.
- Zivadinov R, Pei J, Clayton D, Goldman DE, Winger RC, Cabatingan MS, Dwyer MG, Bergsland N. (2024) Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of neurology, neurosurgery, and psychiatry (May), 95(6): 536-543.
- QSM Consensus Organization Committee , Bilgic B, Costagli M, Chan KS, Duyn J, Langkammer C, Lee J, Li X, Liu C, Marques JP, Milovic C, Robinson SD, Schweser F, Shmueli K, Spincemaille P, Straub S, van Zijl P, Wang Y,. (2024) Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group. Magnetic resonance in medicine (May), 91(5): 1834-1862. doi:10.1002/mrm.30006
